SLC6A3 and Parkinson disease: Several DAT agents have been developed for diagnosing PD and monitoring the treatment of PD patients, based on DAT antagonists such as methylphenidate and cocaine (tropane derivatives).18,40,41 Cocaine analogs (WIN35428) and their derivatives gain potency through halogenation of their phenyl rings.